Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05598801Completed

A Single-center, Prospective, Clinical Study of VersaWrap Utilization in the Hand

Role: lead

NCT06942819Enrolling By Invitation

MRI Outcomes of VersaWrap Nerve Protector Following Surgery

Role: lead

NCT05812092Enrolling By Invitation

Treatment of One and/or Two Level Cervical Degenerative Disc Disease

Role: lead

NCT06415110Enrolling By Invitation

A Prospective Analysis of the Efficacy of Allosync Expand and Autograft Bone Graft in Open Lumbar Spinal Fusion

Role: lead

NCT06415136Enrolling By Invitation

Adjacent Level Anterior Cervical Fusion: SeaSpine Shoreline Versus Removal of Previously Implanted Plate and Replating

Role: lead

NCT06240221Enrolling By Invitation

A Clinical Registry to Track the Real World Use of the Saber-C® Cervical Fusion Device

Role: lead

NCT06415123Enrolling By Invitation

Study to Assess the Performance of MagnEtOs Flex Matrix Compared to Cellular Allograft

Role: lead

NCT07025252Enrolling By Invitation

Outcomes for VersaWrap in Achilles Tendon Repair

Role: lead

All 8 trials loaded